Clinical trials recruiting for OligoProgressive Metastatic Disease
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Stereotactic Body Radiation Therapy (SBRT) | 2 |
| Metastasis directed radiotherapy | 1 |
| SBRT | 1 |
| Stereotactic body radiotherapy | 1 |
| second-line systemic therapy | 1 |
Self-screener
Recruiting trials
- Consolidative Use of Radiotherapy to Block Oligoprogression in Patients With Metastatic Melanoma
- Stereotactic Body Radiotherapy for Oligo-Progression Metastatic Non-Small Cell Lung Cancer
- Stereotactic Body Radiotherapy or Standard of Care for Prostate Oligoprogressive Cancer
- Stereotactic Radiotherapy for Oligoprogressive ER+/HER- Metastatic Breast Cancer, a Prospective Phase 2 Study (Oligopro-Breast)
- The Impact of Metastatic Directed Radiotherapy (MDRT) on Oligoprogressive Castration Resistant Prostate Cancer (CRPC)
Related conditions
Trials recruiting for OligoProgressive Metastatic Disease often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for OligoProgressive Metastatic Disease trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.